CAM
FATE icon

ClariVest Asset Management’s Fate Therapeutics FATE Stock Holding History

ClariVest Asset Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,834
Closed -$265K – 706
2022
Q3 		$265K Sell
11,834
-33
-0.3% -$953 0.01% 416
2022
Q2 		$294K Hold
11,867
– – 0.01% 430
2022
Q1 		$460K Hold
11,867
– – 0.02% 401
2021
Q4 		$695K Sell
11,867
-721
-6% -$40.9K 0.02% 384
2021
Q3 		$746K Sell
12,588
-458
-4% -$35.9K 0.02% 366
2021
Q2 		$1.13M Buy
13,046
+30
+0.2% +$2.42K 0.04% 276
2021
Q1 		$1.07M Sell
13,016
-800
-6% -$76.7K 0.04% 277
2020
Q4 		$1.26M Sell
13,816
-18,751
-58% -$1.16M 0.04% 250
2020
Q3 		$1.3M Sell
32,567
-1,476
-4% -$51.5K 0.04% 276
2020
Q2 		$1.17M Buy
+34,043
New +$1.01M 0.03% 304

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return